Comparison of short-term efficacy between the NP and MVP regimens in the treatment of advanced non-small-cell lung cancer / 中国实用内科杂志

ABSTRACT

0.05).The main side effects were myelosuppresion,gastrointestinal reation and peripheral nerve toxicity and phlebitis.Conclusion The therapeutic effectiveness of NP regimen was better than MVP regimen.There were no significant difference between the two regimens.They can be used as first line chemotheapy for NSCLC.